Trials / Completed
CompletedNCT00573521
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 450 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research will be conducted to determine whether risk factors exist for piperacillin/tazobactam resistance in ESBL organisms.
Detailed description
This is chart review at UPMC. NO human subject interaction will occur.
Conditions
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2007-12-14
- Last updated
- 2018-06-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00573521. Inclusion in this directory is not an endorsement.